Design of Experiment (DoE) for Bioprocess : Design Evaluation Guide
Choosing a DoE design type is only the first step. Before running a single experiment, evaluating whether your chosen design is statistically sound sufficient power, manageable aliasing, acceptable prediction variance, and adequate degrees of freedom — is what separates robust bioprocess studies from ones that yield inconclusive or misleading results.
A poorly evaluated DoE design can result in missing critical effects, confounding important factors, or generating a model with insufficient predictive capability — all costly outcomes in biopharmaceutical development. Design evaluation answers four fundamental questions before any experiment is run.
Why Design Evaluation Matters?
Before running experiments, you must evaluate whether your design is statistically sound. This evaluation ensures you can detect real effects, avoid confounding, and generate reliable models.
Can the design detect an effect of size that matters to you? Power is the probability of correctly identifying a real effect when it exists.
Target: ≥ 80% powerAre any effects entangled with each other? Aliases prevent you from distinguishing which factor truly caused an observed response change.
Target: No main effect aliasingHow precisely can the model predict responses at any point in design space? Prediction variance should be low and uniform across the region of interest.
Target: Stable FDS profileDoes the design have enough runs beyond what the model parameters require to estimate error and validate the model? Too few residual df means unreliable statistics.
Target: ≥ 3 residual dfHow efficiently does the design estimate model coefficients? D-efficiency measures the volume of the confidence ellipsoid — higher is better.
Target: D-efficiency ≥ 80%VIF measures how correlated model terms are with each other. High VIF indicates multicollinearity — inflated parameter uncertainty and unstable estimates.
Target: VIF < 10 (ideally ≈ 1)Statistical Power : Detecting What Matters
Power analysis determines whether your design has enough runs to detect an effect of a given size with acceptable certainty. In bioprocess development, power is typically evaluated at a signal-to-noise ratio relevant to your critical quality attributes (CQAs).
Aliasing and Confounding : Resolving Effect Ambiguity
In fractional factorial designs, not all effects can be independently estimated. Some effects are mathematically indistinguishable — they are aliased. Understanding the alias structure before running the experiment is critical to avoiding uninterpretable results.
| Design Type | Resolution | Main Effects Aliased? | 2FI Aliased with 2FI? | Curvature Estimable? | Typical Use |
|---|---|---|---|---|---|
| Full Factorial (2ᵏ) | Full (V+) | No | No | With centre points | Characterisation |
| Fractional Factorial (Res V) | Resolution V | No | With 3FI only | With centre points | Screening → Char. |
| Fractional Factorial (Res IV) | Resolution IV | No | Yes (2FI = 2FI) | With centre points | Screening only |
| Fractional Factorial (Res III) | Resolution III | Yes (ME = 2FI) | Yes | No | Avoid if possible |
| Definitive Screening Design | Inherent (IV+) | No | No | Yes | Screening + Char. |
| Response Surface (CCC / Box-Behnken) | Full | No | No | Yes (explicit) | Optimisation |
⚠ Resolution III designs in bioprocess: Avoid using Resolution III fractional factorials when interactions between bioprocess parameters (pH × DO, temperature × feed timing) are plausible. In cell culture systems, factor interactions are common — a Resolution IV or DSD is much safer even with the cost of additional runs.
Prediction Variance and FDS Plot
The Fraction of Design Space (FDS) plot is the gold standard tool for evaluating how uniformly a design can predict responses across the entire experimental region. It answers: "For what fraction of the design space can I predict with a given precision?"
Fraction of Design Space (FDS) — Scaled Prediction Variance Profile
A good FDS profile stays flat and below SPV = 2 across at least 80% of the design space. Steep rises at the high end of the FDS plot indicate that predictions near the boundaries of the experimental region are unreliable — a major concern for bioprocess design space definition.
Residual Degrees of Freedom : Ensuring Model Validity
Residual degrees of freedom (df) are the runs remaining after fitting all model terms. They provide the error estimate needed for hypothesis testing, lack-of-fit assessment, and overall model validation.
Comparing Designs Side by Side
When multiple design options exist for the same experimental objective, a structured comparison across evaluation criteria guides the optimal selection. Here is an example comparison for a 5-factor characterisation study in a fed-batch cell culture process.
Note: DSD's key advantage is detecting curvature with far fewer runs. If budget is constrained and curvature is expected in your bioprocess (common in temperature and pH effects on cell growth), DSD is often the superior choice despite slightly lower power.
Pre-Experiment Design Evaluation Checklist
Before executing any DoE in a bioprocess setting, work through this checklist to confirm your design is statistically sound and fit for purpose.
Bioprocess Design of Experiment (DoE) — Full Suite
Statistical Analysis
Report Writing
Scale-up & Down
Support
Need expert DoE design evaluation for your bioprocess?
Graphtal evaluates power, aliasing, prediction variance, and model validity before you run a single experiment.
Tell Us About Your Project
Our team of experienced professionals at Graphtal
is ready to transform your project from idea to
reality, ensuring alignment with your organisation goals through advanced data analytics and
predictive modelling.
Let's simplify your work